Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,688,471
-$1,097,056 QoQ
Shares Held
43,297
-40.4% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#180
of 477 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. CYTK ranks #13 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
35,287 | $4,046,360 |
All Filings in CYTK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,688,471 | 43,297 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,785,527 | 72,607 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,261,295 | 98,541 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,721,775 | 104,108 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,669,036 | 171,581 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,008,686 | 149,507 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $7,899,662 | 167,935 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $11,448,412 | 216,826 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $14,361,438 | 265,069 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $9,778,732 | 139,477 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $21,980,829 | 263,275 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $7,274,322 | 246,922 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $7,320,710 | 224,424 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,726,709 | 191,154 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $10,326,774 | 225,377 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,157,995 | 127,100 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,797,653 | 96,657 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,249,179 | 142,602 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,657,779 | 146,068 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,772,607 | 105,557 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,453,583 | 123,981 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,395,983 | 146,001 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $825,485 | 39,725 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,539,683 | 71,117 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $513,189 | 21,773 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||